Ocular Therapeutix, Inc.
OCUL
$10.04
-$0.06-0.59%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.11% | -37.06% | 6.86% | -2.37% | -5.87% |
| Total Depreciation and Amortization | 44.27% | 2.89% | 16.65% | 4.19% | 4.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.34% | 80.96% | -18.98% | 26.35% | -14.55% |
| Change in Net Operating Assets | -615.59% | 145.79% | -156.36% | 575.36% | -90.02% |
| Cash from Operations | -1.94% | -21.65% | -6.95% | 8.17% | -23.66% |
| Capital Expenditure | 27.78% | -64.21% | 52.63% | -381.37% | 35.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 27.78% | -64.21% | 52.63% | -437.49% | 42.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 777.89% | -99.93% | 4,239.28% | -89.41% | 2,238.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 777.89% | -99.93% | 4,239.28% | -89.41% | 2,238.18% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.27% | -117.94% | 946.14% | -211.84% | 197.72% |